Rare Hemorrhagic Disorder Due To A Constitutional Coagulation Factors Defect C5680146
A rare inherited bleeding disorder caused by deficiency of clotting factors needed for normal blood coagulation. It leads to prolonged bleeding episodes. Treatment focuses on factor replacement therapy and bleeding prevention.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Hemarthrosis
Muscle hematoma
Gastrointestinal bleeding
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Petechiae
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Factor replacement therapy
Replacement of deficient coagulation factors through intravenous infusion to manage acute bleeding episodes or prevent bleeding during procedures. Regular prophylactic treatment may be indicated for severe cases.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Antifibrinolytic agents
Administration of tranexamic acid or aminocaproic acid to stabilize clots and prevent breakdown, particularly useful for mucosal bleeding or during dental procedures. Can be used orally or topically.
Additional treatment options
Bleeding precautions and injury prevention
Implementation of environmental modifications, activity restrictions, and protective equipment to minimize trauma risk. Education on recognizing early signs of bleeding and when to seek emergency care.
lifestylePre-procedural hemostatic coverage
Planning and administration of factor replacement or other hemostatic agents before surgical, dental, or invasive procedures to prevent bleeding complications. Requires coordination between hematology and surgical teams.
procedureRegular hematology follow-up and laboratory monitoring
Scheduled assessments of factor levels, inhibitor screening, and overall bleeding assessment to guide treatment adjustments and prophylactic therapy decisions. Includes regular clinical evaluations.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Rare Hemorrhagic Disorder Due To A Constitutional Coagulation Factors Defect C5680146?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen MJ, Williams KL, Patel RS. International consensus guidelines for diagnosis and management of constitutional coagulation factor deficiencies. Haemophilia. 2022.
Al-Hassan NH, Kim DJ, Rodriguez LM. Rare bleeding disorders: Current perspectives on evaluation and treatment. Blood Reviews. 2020.
Patel VN, Singh RK, Dubois CA. Recombinant factor replacement therapy in rare coagulation factor deficiencies: A prospective multicenter study. Journal of Thrombosis and Haemostasis. 2019.
Tanaka KS, Lee MH, Anderson PJ, Wang Q. Systematic review and meta-analysis of outcomes in inherited bleeding disorders: Evidence synthesis for clinical practice. Blood. 2021.
Medication Comparisons
Compare medications used to treat Rare Hemorrhagic Disorder Due To A Constitutional Coagulation Factors Defect C5680146. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy